A De novo HDAC2 variant in a patient with features consistent with Cornelia de Lange syndrome phenotype

Victoria F. Wagner, Paul R. Hillman, Allison D. Britt, Joseph Ray, Laura S. Farach

Research output: Contribution to journalArticle

Abstract

Cornelia de Lange syndrome (CdLS) is an autosomal dominant genetic disorder caused by pathogenic variants in NIPBL, RAD21, SMC3, HDAC8, or SMC1A; all of which code for proteins that are components of, or interact with, the cohesin complex. Despite the identification of multiple genes associated with CdLS, over 25% of individuals strongly suspected to have CdLS have negative genetic testing, indicating that there are additional genes associated with the condition. HDAC2 codes for histone deacetylase 2 (HDAC2) and, like HDAC8, is a Class 1 histone deacetylase. We present a patient with a novel de novo variant in HDAC2 with many clinical features consistent with CdLS including severe developmental delay, limb abnormalities, congenital heart defect, cryptorchidism and hypoplastic genitalia, growth retardation, and characteristic craniofacial features. Although variants in HDAC2 are not currently associated with human disease, the variant identified in this patient is within a highly conserved amino acid residue and has not been observed in healthy populations. This information, along with the patient's clinical presentation and the functional similarity between the HDAC2 and HDAC8 proteins, suggests that HDAC2 should be further investigated as a candidate gene for CdLS or a CdLS-like syndrome.

Original languageEnglish (US)
Pages (from-to)852-856
Number of pages5
JournalAmerican Journal of Medical Genetics, Part A
Volume179
Issue number5
DOIs
StatePublished - May 1 2019

Fingerprint

Histone Deacetylase 2
De Lange Syndrome
Phenotype
Histone Deacetylase 1
Genes
Inborn Genetic Diseases
Cryptorchidism
Genitalia
Congenital Heart Defects
Genetic Testing
Proteins
Extremities
Amino Acids
Growth

Keywords

  • Cornelia de Lange syndrome
  • dysmorphic facies
  • HDAC2
  • multiple congenital anomalies

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

A De novo HDAC2 variant in a patient with features consistent with Cornelia de Lange syndrome phenotype. / Wagner, Victoria F.; Hillman, Paul R.; Britt, Allison D.; Ray, Joseph; Farach, Laura S.

In: American Journal of Medical Genetics, Part A, Vol. 179, No. 5, 01.05.2019, p. 852-856.

Research output: Contribution to journalArticle

Wagner, Victoria F. ; Hillman, Paul R. ; Britt, Allison D. ; Ray, Joseph ; Farach, Laura S. / A De novo HDAC2 variant in a patient with features consistent with Cornelia de Lange syndrome phenotype. In: American Journal of Medical Genetics, Part A. 2019 ; Vol. 179, No. 5. pp. 852-856.
@article{d128f3ea1f34424da0a94fb3dbf33b9b,
title = "A De novo HDAC2 variant in a patient with features consistent with Cornelia de Lange syndrome phenotype",
abstract = "Cornelia de Lange syndrome (CdLS) is an autosomal dominant genetic disorder caused by pathogenic variants in NIPBL, RAD21, SMC3, HDAC8, or SMC1A; all of which code for proteins that are components of, or interact with, the cohesin complex. Despite the identification of multiple genes associated with CdLS, over 25{\%} of individuals strongly suspected to have CdLS have negative genetic testing, indicating that there are additional genes associated with the condition. HDAC2 codes for histone deacetylase 2 (HDAC2) and, like HDAC8, is a Class 1 histone deacetylase. We present a patient with a novel de novo variant in HDAC2 with many clinical features consistent with CdLS including severe developmental delay, limb abnormalities, congenital heart defect, cryptorchidism and hypoplastic genitalia, growth retardation, and characteristic craniofacial features. Although variants in HDAC2 are not currently associated with human disease, the variant identified in this patient is within a highly conserved amino acid residue and has not been observed in healthy populations. This information, along with the patient's clinical presentation and the functional similarity between the HDAC2 and HDAC8 proteins, suggests that HDAC2 should be further investigated as a candidate gene for CdLS or a CdLS-like syndrome.",
keywords = "Cornelia de Lange syndrome, dysmorphic facies, HDAC2, multiple congenital anomalies",
author = "Wagner, {Victoria F.} and Hillman, {Paul R.} and Britt, {Allison D.} and Joseph Ray and Farach, {Laura S.}",
year = "2019",
month = "5",
day = "1",
doi = "10.1002/ajmg.a.61101",
language = "English (US)",
volume = "179",
pages = "852--856",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - A De novo HDAC2 variant in a patient with features consistent with Cornelia de Lange syndrome phenotype

AU - Wagner, Victoria F.

AU - Hillman, Paul R.

AU - Britt, Allison D.

AU - Ray, Joseph

AU - Farach, Laura S.

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Cornelia de Lange syndrome (CdLS) is an autosomal dominant genetic disorder caused by pathogenic variants in NIPBL, RAD21, SMC3, HDAC8, or SMC1A; all of which code for proteins that are components of, or interact with, the cohesin complex. Despite the identification of multiple genes associated with CdLS, over 25% of individuals strongly suspected to have CdLS have negative genetic testing, indicating that there are additional genes associated with the condition. HDAC2 codes for histone deacetylase 2 (HDAC2) and, like HDAC8, is a Class 1 histone deacetylase. We present a patient with a novel de novo variant in HDAC2 with many clinical features consistent with CdLS including severe developmental delay, limb abnormalities, congenital heart defect, cryptorchidism and hypoplastic genitalia, growth retardation, and characteristic craniofacial features. Although variants in HDAC2 are not currently associated with human disease, the variant identified in this patient is within a highly conserved amino acid residue and has not been observed in healthy populations. This information, along with the patient's clinical presentation and the functional similarity between the HDAC2 and HDAC8 proteins, suggests that HDAC2 should be further investigated as a candidate gene for CdLS or a CdLS-like syndrome.

AB - Cornelia de Lange syndrome (CdLS) is an autosomal dominant genetic disorder caused by pathogenic variants in NIPBL, RAD21, SMC3, HDAC8, or SMC1A; all of which code for proteins that are components of, or interact with, the cohesin complex. Despite the identification of multiple genes associated with CdLS, over 25% of individuals strongly suspected to have CdLS have negative genetic testing, indicating that there are additional genes associated with the condition. HDAC2 codes for histone deacetylase 2 (HDAC2) and, like HDAC8, is a Class 1 histone deacetylase. We present a patient with a novel de novo variant in HDAC2 with many clinical features consistent with CdLS including severe developmental delay, limb abnormalities, congenital heart defect, cryptorchidism and hypoplastic genitalia, growth retardation, and characteristic craniofacial features. Although variants in HDAC2 are not currently associated with human disease, the variant identified in this patient is within a highly conserved amino acid residue and has not been observed in healthy populations. This information, along with the patient's clinical presentation and the functional similarity between the HDAC2 and HDAC8 proteins, suggests that HDAC2 should be further investigated as a candidate gene for CdLS or a CdLS-like syndrome.

KW - Cornelia de Lange syndrome

KW - dysmorphic facies

KW - HDAC2

KW - multiple congenital anomalies

UR - http://www.scopus.com/inward/record.url?scp=85062367086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062367086&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.61101

DO - 10.1002/ajmg.a.61101

M3 - Article

C2 - 30806031

AN - SCOPUS:85062367086

VL - 179

SP - 852

EP - 856

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 5

ER -